U.S. Court of Appeals for the Federal Circuit, 2024

Fate Therapeutics, Inc. v. Shoreline Biosciences, Inc.

Fate Therapeutics, Inc. v. Shoreline Biosciences, Inc.
U.S. Court of Appeals for the Federal Circuit · Decided November 6, 2024
Fate Therapeutics, Inc. v. Shoreline Biosciences, Inc.

Opinion

Case: 24-1021 Document: 53 Page: 1 Filed: 11/06/2024

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

FATE THERAPEUTICS, INC., WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH,

Plaintiffs-Appellants v.

SHORELINE BIOSCIENCES, INC.,

Defendant-Cross-Appellant ______________________

2024-1021, 24-1055 ______________________

Appeal from the United States District Court for the Southern District of California in No. 3:22-cv-00676-H- MSB, Senior Judge Marilyn L. Huff. ______________________

ORDER

The parties having so agreed, it is ordered that: (1) The proceeding is DISMISSED under Fed. R. App. P. 42 (b).

Case: 24-1021 Document: 53 Page: 2 Filed: 11/06/2024

2 FATE THERAPEUTICS, INC. V. SHORELINE BIOSCIENCES, INC.

(2) Each side shall bear their own costs.

FOR THE COURT

November 6, 2024

Date

ISSUED AS A MANDATE: November 6, 2024

Case-law data current through September 30, 2026. Source: CourtListener bulk data.